Monte Rosa Therapeutics Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Monte Rosa Therapeutics Inc. | GLUE - NASDAQ |
$17.00-$19.00 | $19.00 | $22.00 | 11.7 million | 6/24/2021 |
| JP Morgan, Cowen, Piper Sandler, Guggenheim | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-04 Terms Added 2021-06-21 | ||||||
Monte Rosa Therapeutics Inc. Quote & Chart - Click for current quote - GLUE
IPO Boutique aggregates information on public companies and private companies, such as "GLUE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Monte Rosa Therapeutics Inc. (adapted from Monte Rosa Therapeutics Inc. prospectus):
They are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically-relevant proteins.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically-relevant proteins.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "GLUE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.